News

QuotedData’s morning briefing 16 June 2025 – ESO, CLDN, BBH, SSIT, ORIT, AGR, TFG

person looking at a laptop screen

In QuotedData’s morning briefing 16 June 2025, EPE Special Opportunities intends to extend the maturity date of its 8% loan notes by a year, a director of Caledonia has received and sold shares back to its employee share trust, Bellevue Healthcare has been granted permission to repurchase shares, Seraphim Space will be taking part in Mello Monday, Octopus Renewables says that it will engage with dissenting shareholders following a significant vote against the re-election of one of its directors, and Tetragon Financial is selling a stake in Equitix.

  • EPE Special Opportunities (ESO) has announced that it intends to extend the maturity date of its 8% unsecured loan notes by one year. The notes, which were originally set to mature on 23 July 2025, will now be extended to 23 July 2026 – the eleventh anniversary of the original loan note instrument dated 23 July 2015. This extension is being made under clause 5.1(b) of the loan note instrument, which allows ESO to extend the final repayment date provided it remains in compliance with the terms of the instrument as of 23 July 2025. As part of the extension, the interest rate on the notes will rise from 8% to 8.5% per annum, effective from 23 July 2025.
  • Caledonia (CLDN) has announced a transaction involving one of its directors, Mathew Masters, under the company’s 2020 deferred bonus plan (DBP). On 12 June 2025, Mr Masters received 3,870 ordinary shares at no cost, with the shares being sourced from Caledonia’s Employee Share Trust. Immediately following the award, Mr Masters sold the full allocation back to the trust at a price of 3,780p per share (transaction value £146,286). Following these transactions, Mr Masters’ beneficial holding in the company stands at 67,145 shares, representing 0.13% of voting rights. He also holds 98,814 shares under the company’s performance share scheme (0.19%) and a further 3,652 shares under the DBP (0.01%). No change in his overall economic exposure to CLDN has occurred as a result of these trades.
  • Bellevue Healthcare (BBH) has announced that the special resolution proposed at its General Meeting on 13 June – giving the trust the authority to repurchase its own shares – has been approved by shareholders. This authority supports the ongoing implementation of BBH’s zero discount policy that is designed to manage the discount to NAV and promote shareholder value. The vote saw strong support, with 93.66% (46.8m votes) cast in favour and 6.34% (3.2m votes) against. A further 15,543 votes were withheld. At the time of the meeting, the trust had 315.2m shares in issue, with 130.8m held in treasury. As such, the total number of voting rights stood at just over 184.3m shares.
  • Seraphim Space Investment Trust (SSIT) will be participating in the upcoming MelloMonday investor event on 16 June 2025. The event, hosted via Zoom Webinar, will begin at 5:00pm and Mark Boggett, CEO and general partner at Seraphim Space Manager LLP, is scheduled to present at 6:30pm. He will take questions from attendees as part of his presentation. Investors can register for a free ticket using the code SHFREE. A recording of the session will be circulated to all registrants within 48 hours.
  • Octopus Renewables Infrastructure Trust (ORIT) has confirmed that all resolutions put to shareholders at its Annual General Meeting on 13 June 2025 were duly passed. While most resolutions attracted high levels of approval, the re-election of Philip Austin as a director saw a notable 19.74% vote against. The board has acknowledged this and says that it will engage with dissenting shareholders to understand and address their concerns.
  • The board of Assura (AGR) says that it is reviewing the revised terms of the PHP offer (made last week) with its advisers and will continue to engage in extensive shareholder consultation. It will send a circular to Assura shareholders by no later than 27 June 2025, setting out its views on the PHP offer. In the meantime, it has advised Assura shareholders to take no action in relation to the PHP offer.
  • Hunter Point Capital (HPC), an independent investment firm providing capital solutions and strategic support to alternative asset managers, has agreed to acquire a minority stake in Equitix, a leading international investor, developer and fund manager in infrastructure. HPC is acquiring a 16.1% stake in the business at an implied enterprise value of £1.3bn, excluding net debt. HPC’s stake is being acquired from two existing shareholders: approximately 14.6% from TFG Asset Management, Tetragon’s diversified alternative asset management business, and 1.5% from Equitix management. Equitix was founded in 2007 and Tetragon acquired a controlling stake in the business in 2015. Since being acquired by Tetragon, Equitix has grown from £1.3bn to over £11.7bn in assets under management with a broad sector reach across social infrastructure, transport, renewable power, environmental services, network utilities and data infrastructure.

We also have:

Stories you may have missed from Friday:

Matthew Read
Written By Matthew Read

Head of Production and Senior Research Analyst

Leave a Reply

Your email address will not be published. Required fields are marked *